検索結果

ed approval for a partial change in the marketing authorization of “Aibeta® Combination Eye Drops” (generic name: brimonidine tartrate and timolol maleate, hereinafter referred to as “the new formulat...

ed approval for a partial change in the marketing authorization of “Aibeta® Combination Eye Drops” (generic name: brimonidine tartrate and timolol maleate, hereinafter referred to as “the new formulat...

Product Development Policy | Research & Development | SENJU Pharmaceutica

hypertension, etc. We also contributed to reducing the economic burden on patients by using various generic drugs and biosimilars. In addition, there are various other eye diseases. The World Report o...

hei Yoshida; hereinafter: Senju) is pleased to announce that “Avarept® Ophthalmic suspension 0.3%” (Generic Name: Motugivatrep, development code: SJP-0132, hereinafter: Product), discovered and licens...

hei Yoshida; hereinafter: Senju) is pleased to announce that “Avarept® Ophthalmic suspension 0.3%” (Generic Name: Motugivatrep, development code: SJP-0132, hereinafter: Product), discovered and licens...